the aid library

LIST OPTIONS

Democratic Republic of Timor-Leste Ministry of Health - Comprehensive TB Guidelines for National Tuberculosis Program, V Edition

Government of Timor-Leste; World Health Organization (2023) CC

The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death. The salient observations are as follows: In 2018, 487 (12.5%) of the... more

Download (841)

View PDF (1699)

A global brief on vector-borne diseases

World Health Organization (2014) C_WHO

With this World Health Day, WHO is drawing attention to a group of diseases that are spread by insects and other vectors, the heavy health and economic burdens they impose, and what needs to be done to reduce these burdens. Many of these diseases have been historically confined to distinct geographi... more

Download (811)

View PDF (1526)

Ethics Guidance for the Implementation of the End TB Strategy

World Health Organization WHO (2017) C_WHO

Download (366)

View PDF (350)

Framework for One Health Practice in National Public Health Institutes
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) CC

Download (468)

View PDF (405)

Decontamination and reprocessing of medical devices for health care facilities: aide-memoire

World Health Organization WHO (2022) CC

Decontamination of medical devices plays an important role in the prevention of health care-associated infections. It includes cleaning, disinfection and/or sterilization. The processes involved in decontamination are complex, require specific infrastructure and equipment, and involve several sequen... more

Download (791)

View PDF (1794)

FAST Poster TB Settings

United States Agency for International Development (USAID) (2013)

This core package of materials provides a comprehensive introduction to the FAST strategy: a focused approach to stopping TB spread in congregate settings. In English, FAST stands for: Finding TB cases Actively, Separating safely, and Treating effectively. FAST focuses health care workers on ... more

Download (238)

View PDF (274)

Reseña normativa de la OMS: mantenimiento de las medidas de prevención y control de la COVID-19 en los establecimientos de salud, 14 de septiembre de 2022

Organización Mundial de la Salud OMS (2022) C_WHO

This document aims to encourage countries to develop and implement policies to maintain and strengthen IPC programmes and measures in health care facilities in the context of the current ongoing transmission of the SARS-CoV-2, with recognition that epidemiological trends may vary and the risk of tra... more

Download (783)

View PDF (1688)

Surgical site infection prevention recommendations: Intraoperative Period

World Health Organization WHO (2018) C_WHO

Download (328)

View PDF (396)

HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma - A Tale of Two Proteins: Tax and HBZ

Chou-Zen Giam; Semmes, Oliver John (2016) CC3

published in: Viruses 2016, 8, 161

Download (1339)

View PDF (3258)

WHO/UNICEF Strategic Plan for Polio Outbreak Response in the Middle East

The Polio Global Eradication Initiative WHO (2013)

THE SYRIAN ARAB REPUBLIC, IRAQ, JORDAN, LEBANON, TURKEY, WEST BANK AND GAZA STRIP, EGYPT

Download (761)

View PDF (1626)

District guidelines for yellow fever surveillance

World Health Organization WHO (1998) C_WHO

Download (1316)

View PDF (3385)

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended

World Health Organization WHO (2018) C_WHO

These WHO guidelines which were updated in 2018, are valid for any country and suitable to local adaptations, and take account of the strength of available scientific evidence, the cost and resource implications, and patient values and preferences. The 2018 edition of the guidelines includes the re... more

Download (1230)

View PDF (3292)

Mesures de Base contre les infections associées aux soins

Organisation Mondiale de la Santé OMS (2007)

Download (892)

View PDF (2080)

Core components of infection prevention and control programmes in health care

World Health Organization (2011)

External Link

Guidance on chlamydia control in Europe

European Centre for Disease Prevention and Control (2016) C1

This document updates the 2009 ECDC guidance on chlamydia control in Europe. It was developed by a technical expert group which conducted a critical review of the scientific evidence on the epidemiology of chlamydia and the effectiveness of screening programmes. The aim of this guidance is to suppo... more

External Link

Poorly Designed PPE a Global Problem forWomen HealthWorkers

Kuehn, B.M. (2022) C1

Download (272)

View PDF (358)

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

1.0 PURPOSE To define the procedure for the conduct of in-person meetings in both healthcare and community settings in response to COVID-19 and with respect to Public Health and Social Measures (PHSMs) to reduce the risk of disease transmission. A general risk assessment must be conducted to inform... more

Download (311)

View PDF (366)

Overview of technologies for the treatment of infectious and sharp waste from health care facilities

World Health Organization WHO (2020) C_WHO

This document provides an overview of specific health care waste technologies for the treatment of solid infectious and sharp waste. For each technology, details of its operation, effects on the environment and health, requirements for installation, capacities for treating waste, examples of consuma... more

Download (311)

View PDF (328)

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2022) CC

Health care waste can be difficult to treat and dispose of safely. The environmental and health impacts of waste put extra pressure on resources. Therefore, it is important to try and reduce the quantities of waste wherever possible. Ensure waste is segregated properly at the point of disposal. It i... more

Download (331)

View PDF (442)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Framework for One Health Practice in National Public Health Institutes recommended

Global guidelines on the prevention of surgical site infection. 2nd edition recommended

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19 recommended

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa recommended

Framework for One Health Practice in National Public Health Institutes
recommended

Global guidelines on the prevention of surgical site infection. 2nd edition
recommended

Infection Prevention and Control (IPC) Standard Operating Procedure (SOP) for Training/Meetings in the context of COVID-19
recommended

FAQs: Waste Management for COVID-19 in Healthcare Settings for Africa
recommended